NINDS Advisory Council Agenda - May 24, 2018

NINDS Advisory Council Agenda - May 24, 2018

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Neurological Disorders and Stroke

 

National Advisory Neurological Disorders and Stroke Council

202nd Meeting

May 24, 2018

Neuroscience Center (NSC) Building, Conference Room C/D
6001 Executive Boulevard
Rockville, Maryland 20852

NIH Videocast Website: http://videocast.nih.gov/

 

AGENDA

May 24, 2018

OPEN SESSION

 

8:00 a.m.

I.  Call to Order and Opening Remarks
     Dr. Walter Koroshetz, Chairperson, Director, NINDS

8:05 a.m.

II.  Report of the Director, Division of Extramural Activities, NINDS
      Dr. Robert Finkelstein, Executive Secretary, NANDS Council

  1. Consideration of Minutes of February 1, 2018, Meeting
  2. Confirmation of Dates for Future Council Meetings        

                                                Thursday, September 13, 2018

                                                Thursday, February 14, 2019   

                                                Thursday, May 23, 2019                 

                                                Thursday, September 5, 2019                       

                          ***NEW DATES***

                                                Thursday, February 6, 2020

                                                Thursday, May 28, 2020

                                                Thursday, September 10, 2020

      C.     Other Items

                           Expedited Review Process

                           Extramural Announcements

8:15 a.m.

III.  Report of the Director, NINDS
       Dr. Walter Koroshetz

9:15 a.m.

IV.  The MD CARE Act
       Dr. Glen Nuckolls, Neurogenetics Cluster
       Dr. Heather Rieff, NINDS Office of Science Policy and Planning

9:45 a.m.

V.  NINDS Funding Overview
     Dr. Robert Finkelstein
     Dr. Amy Adams, Office of Scientific Liaison

10:15 a.m.

BREAK

10:30 a.m.

VI.  Update from the Scientific Director of Intramural Research
       Dr. Alan Koretsky, Scientific Director, NINDS

11:30 a.m.

VII.  Update from the NIMH
         Dr. Joshua Gordon, Director, NIMH

12:00 a.m.

LUNCH

1:00 p.m.

VIII. Initiatives Requiring Concept Clearance:

Comparative Effectiveness Research in Clinical Neurosciences
Dr. Adam Hartman, Division of Clinical Research

Discover and Validate Novel Targets for Safe and Effective Pain Treatment
Dr. Michael Oshinsky, Systems and Cognitive Neuroscience Cluster

Platform Screen Program for Pain (PSPP)
Dr. John Kehne, Division of Translational Research

2:00 p.m.

BREAK

2:15 p.m.

CLOSED SESSION

This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

IX.  Review of Conflict of Interest, Confidentiality, and Council Procedures
       Council Consideration of Pending Applications  
       Dr. Robert Finkelstein 

4:45 p.m.

CLOSED SESSION (Continued)

This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

X.  Review of the Division of Intramural Research Board of Scientific Counselors’ Reports
       Dr. Alan Koretsky

5:15 p.m. **

ADJOURNMENT